InnoCan Pharma (TSE:INNO) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
InnoCan Pharma celebrates the inclusion of its Scientific Advisory Board member, Dr. Joseph Pergolizzi, in Stanford University’s list of the top 2% most-cited scientists. His influential work in medical science and role in supporting InnoCan’s pharmaceutical R&D and FDA filings highlight his contribution to the company’s innovative healthcare solutions.
For further insights into TSE:INNO stock, check out TipRanks’ Stock Analysis page.